Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. Februar 2024 07:25 ET | Quelle: Arch Biopartners

Arch Biopartners Has Pre-IND Meeting With FDA to Discuss Repurposing Cilastatin as a New Treatment to Prevent Acute Kidney Injury

TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it had a pre-investigational new drug...
24. März 2022 08:08 ET | Quelle: Research and Markets

Global Autoimmune Disease Therapeutics Market to 2025 - by Drug Class, Indication and Region

Dublin, March 24, 2022 (GLOBE NEWSWIRE) -- The "Global Autoimmune Disease Therapeutics Market: Analysis By Drug Class By Indication By Region Size & Trends with Impact of Covid-19 and Forecast...
23. Februar 2021 08:43 ET | Quelle: Research and Markets

Global Autoimmune Disease Therapeutics Market (2021 to 2025) - Size & Forecast with Impact Analysis of COVID-19

Dublin, Feb. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Autoimmune Disease Therapeutics Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)" report has been added to...